Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Change in Receivables: 2024

Historic Change in Receivables for Gossamer Bio (GOSS) over the last 1 years, with Dec 2024 value amounting to $5.3 million.

  • Gossamer Bio's Change in Receivables fell 43.76% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year change of. This contributed to the annual value of $5.3 million for FY2024, which is N/A change from last year.
  • Per Gossamer Bio's latest filing, its Change in Receivables stood at $5.3 million for FY2024.
  • Gossamer Bio's Change in Receivables' 5-year high stood at $5.3 million during FY2024, with a 5-year trough of $5.3 million in FY2024.
  • Moreover, its 1-year median value for Change in Receivables was $5.3 million (2024), whereas its average is $5.3 million.